The Safety and efficacy of Kangduo endoscopic robot surgery system in Radical prostatectomy

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100045994

Enrollment

Unknown

Registered

2021-05-01

Start date

2021-05-20

Completion date

Unknown

Last updated

2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostatic cancer

Interventions

experimental group:endoscopic surgical system(KD-SR-01)

Eligibility

Sex/Gender

Male

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Prostate cancer patients who need radical prostatectomy; 2.Aged 18 to 75 years; 3.Those who agree to sign the informed consent, follow the doctor's advice and follow up regularly.

Exclusion criteria

Exclusion criteria: 1.Patients with severe uncontrolled disease or acute infection; 2.The patients with cardiovascular and cerebrovascular diseases, blood system diseases and diabetes can not be controlled and can not reach the operation standard; 3.Those who have immune system disease and can't control, can't reach the operation standard; 4.Previous abdominal and pelvic surgery history, severe abdominal and pelvic adhesions.

Design outcomes

Primary

Measure	Time frame
Surgical margin;Postoperative urinary incontinence;	—

Secondary

Measure	Time frame
Postoperative lower urinary tract obstruction;	—

Countries

China

Contacts

Public ContactZhou Liqun

zhoulqmail@sina.com+86 13601239241

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026